<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font22 { font-size : 22; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font26">(.) </span>
   <span class="font22">the </span>
   <span class="font17">were </span>
   <span class="font15">with </span>
   <span class="font14">was </span>
   <span class="font14">HIV- </span>
   <span class="font13">resistance </span>
   <span class="font13">The </span>
   <span class="font12">for </span>
   <span class="font12">patients </span>
   <span class="font12">{background </span>
   <span class="font12">HIV </span>
   <span class="font12">drug </span>
   <span class="font12">among </span>
   <span class="font12">mutations </span>
   <span class="font12">prevalence </span>
   <span class="font12">this </span>
   <span class="font12">(.%, </span>
   <span class="font12">margin </span>
   <span class="font12">that </span>
   <span class="font11">{border-style </span>
   <span class="font11">/), </span>
   <span class="font11">from </span>
   <span class="font11">have </span>
   <span class="font11">DRMs </span>
   <span class="font11">are </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">found </span>
   <span class="font11">men </span>
   <span class="font11">CRF_AE </span>
   <span class="font11">HIVDR </span>
   <span class="font11">which </span>
   <span class="font11">antiretroviral </span>
   <span class="font11">has </span>
   <span class="font11">ART </span>
   <span class="font11">CRF_BC </span>
   <span class="font11">China </span>
   <span class="font11">treatment </span>
   <span class="font11">Chengdu </span>
   <span class="font11">[]. </span>
   <span class="font11">who </span>
   <span class="font11">.%, </span>
   <span class="font11">cases </span>
   <span class="font11">high </span>
   <span class="font10">(.%) </span>
   <span class="font10">Sichuan </span>
   <span class="font10">infected </span>
   <span class="font10">low </span>
   <span class="font10">recombinant </span>
   <span class="font10">resistant </span>
   <span class="font10">study </span>
   <span class="font10">subtypes </span>
   <span class="font10">Drug </span>
   <span class="font10">cell </span>
   <span class="font10">receiving </span>
   <span class="font10">subtype </span>
   <span class="font10">â€ƒ~ </span>
   <span class="font10">(/, </span>
   <span class="font10">CRF_B </span>
   <span class="font10">HIV/AIDS </span>
   <span class="font10">may </span>
   <span class="font10">most </span>
   <span class="font10">px; </span>
   <span class="font10">reverse </span>
   <span class="font10">sex </span>
   <span class="font10">therapy </span>
   <span class="font10">years </span>
   <span class="font10">{font-family </span>
   <span class="font10">Chengdu, </span>
   <span class="font10">associated </span>
   <span class="font10">been </span>
   <span class="font10">count </span>
   <span class="font10">data </span>
   <span class="font10">failure </span>
   <span class="font10">font-size </span>
   <span class="font10">identified </span>
   <span class="font10">inhibitors </span>
   <span class="font10">observed </span>
   <span class="font10">showed </span>
   <span class="font10">surveillance </span>
   <span class="font10">transcriptase </span>
   <span class="font10">transmission </span>
   <span class="font10">(.%), </span>
   <span class="font10">China: </span>
   <span class="font10">National </span>
   <span class="font10">Table </span>
   <span class="font10">Yunnan </span>
   <span class="font10">al.The </span>
   <span class="font10">all </span>
   <span class="font10">also </span>
   <span class="font10">clinical </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">first </span>
   <span class="font10">first-line </span>
   <span class="font10">indicating </span>
   <span class="font10">individuals </span>
   <span class="font10">one </span>
   <span class="font10">pol </span>
   <span class="font10">resistance. </span>
   <span class="font10">subtypes, </span>
   <span class="font10">using </span>
   <span class="font10">â€ƒUnknown </span>
   <span class="font10">.). </span>
   <span class="font10">/). </span>
   <span class="font10">Acquired </span>
   <span class="font10">All </span>
   <span class="font10">CRF </span>
   <span class="font10">China, </span>
   <span class="font10">Immune </span>
   <span class="font10">MI/V </span>
   <span class="font10">Research </span>
   <span class="font10">Resistance </span>
   <span class="font10">This </span>
   <span class="font10">[], </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">characteristics </span>
   <span class="font10">contact </span>
   <span class="font10">distribution </span>
   <span class="font10">had </span>
   <span class="font10">highly </span>
   <span class="font10">immune </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">not </span>
   <span class="font10">other </span>
   <span class="font10">potential </span>
   <span class="font10">predicted </span>
   <span class="font10">relatively </span>
   <span class="font10">samples </span>
   <span class="font10">solid; </span>
   <span class="font10">strains </span>
   <span class="font10">study. </span>
   <span class="font10">such </span>
   <span class="font10">treatment-experienced </span>
   <span class="font10">viral </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(/) </span>
   <span class="font10">.%), </span>
   <span class="font10">CJY, </span>
   <span class="font10">CRF_BC, </span>
   <span class="font10">Center </span>
   <span class="font10">DR, </span>
   <span class="font10">DR. </span>
   <span class="font10">Deficiency </span>
   <span class="font10">FTC </span>
   <span class="font10">However, </span>
   <span class="font10">Journal </span>
   <span class="font10">NNRTI-associated </span>
   <span class="font10">NNRTIs. </span>
   <span class="font10">NRTI-associated </span>
   <span class="font10">NRTIs </span>
   <span class="font10">PI-associated </span>
   <span class="font10">Province </span>
   <span class="font10">Subtypes </span>
   <span class="font10">analyzed </span>
   <span class="font10">area. </span>
   <span class="font10">bold </span>
   <span class="font10">courier; </span>
   <span class="font10">detected </span>
   <span class="font10">during </span>
   <span class="font10">em; </span>
   <span class="font10">epidemic </span>
   <span class="font10">gene </span>
   <span class="font10">genetic </span>
   <span class="font10">infection </span>
   <span class="font10">intermediate </span>
   <span class="font10">novel </span>
   <span class="font10">number </span>
   <span class="font10">overall </span>
   <span class="font10">patients. </span>
   <span class="font10">people </span>
   <span class="font10">population </span>
   <span class="font10">prevention </span>
   <span class="font10">primary </span>
   <span class="font10">profiles </span>
   <span class="font10">pt;} </span>
   <span class="font10">regimen </span>
   <span class="font10">reported </span>
   <span class="font10">sequenced </span>
   <span class="font10">similar </span>
   <span class="font10">study, </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">then </span>
   <span class="font10">total </span>
   <span class="font10">transmitted </span>
   <span class="font10">virologic </span>
  </p>
 </body>
</html>
